News from us and our partners
Tags
Topics
0 results
Cure51 raises a €15 million seed round to harness the natural power of cancer survivors to develop first in class treatments and transform cancer into a curable disease
Moon Surgical's Maestro System powered by NVIDIA Holoscan paves the way to next-generation laparoscopy, with over 200 patients treated
Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG
Sofinnova Partners portfolio company Amolyt Pharma to be acquired by AstraZeneca
Amolyt Pharma enters into definitive agreement to be acquired by AstraZeneca
Mission Therapeutics raises £25.2 million to progress clinical candidates in the area of mitophagy
Sensorion announces it has met primary endpoint for SENS-401 Phase 2a Clinical Study for residual hearing preservation
Signature of a partnership agreement with Kiro
AFYREN is ramping up its efforts to create a new path for organic waste recovery
Gradient Denervation Technologies enrolls first patient in early feasibility study of pulmonary artery denervation system
Asceneuron expands scientific Advisory Board with world leading experts in neurodegenerative diseases
Sitryx Therapeutics makes key appointments to strengthen business operations and progress immunometabolism-targeting pipeline into clinical development
Mainstay Medical announces US$125 million equity financing transaction
HighLife appoints Prof. Stephen Brecker Chief Medical Officer
Ex-Google DeepMind and Owkin scientists team up to create Bioptimus to build the first universal AI foundation model for biology